ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has reported its financial results for its second quarter ended June 30, 2008. Net revenues for the quarter were $218.3 million, representing a 48.5% increase ...read more

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) have announced the two-year anniversary of TYSABRI(R) (natalizumab) as a treatment for relapsing forms of multiple sclerosis (MS), marking the reintroduction of the product in the United States (US) and the first international ...read more

SFI has announced the launch of the new SFI Short Term Travel Fellowship Supplement, designed to enable team members in an SFI funded group to collaborate on research projects in laboratories outside the Republic of Ireland for a period of up to 3 calendar months.

...read more

Realtime Technologies, a leading provider of electronic manufacturing and design services, has (July 16, 2008)launched SHIMMERT, a hardware research platform designed for wearable health sensing in both connected and wireless environments. SHIMMER-which stands for Sensing Health with Intelligence, ...read more

Proxy Biomedical has (Monday, 21 July 2008) opened its new manufacturing premises in an Udaras na Gaeltachta facility in Spiddal in Co Galway. The company, which specialises in the research, development, production and marketing of biomaterials for the repair and regeneration of tissue, plans to ...read more